Provided by Tiger Trade Technology Pte. Ltd.

Oyster Point Pharma

11.17
0.0000
Volume:- -
Turnover:23.31M
Market Cap:303.21M
PE:-1.68
High:11.17
Open:11.17
Low:11.17
Close:11.17
52wk High:18.30
52wk Low:3.46
Shares:27.14M
Float Shares:8.93M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6407
EPS(LYR):-3.8661
ROE:-306.38%
ROA:-65.11%
PB:-13.66
PE(LYR):-2.89

Loading ...

Company Profile

Company Name:
Oyster Point Pharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. The company's lead product candidate is OC-01, a nicotinic acetylcholine receptor agonist that has completed Phase III clinical trial for the treatment of signs and symptoms of dry eye disease. It is also developing OC-01 for neurotrophic keratopathy. Oyster Point Pharma, Inc. was incorporated in 2015 and is headquartered in Princeton, New Jersey.